Abstract
Background/Objectives
Do the distributions of surface area of non-perfusion (NP) and neovascularization (NV) on ultra-widefield fluorescein angiography (UWF FA) in patients with diabetic retinopathy (DR) differ significantly?
Subjects/Methods
Inclusion criteria were patients who had a UWF FA taken for DR at the Kellogg Eye Center from January 2009 to May 2018. Exclusion criteria included previous panretinal photocoagulation and significant media opacity (e.g., vitreous haemorrhage or significant cataract). UWF FAs were manually segmented for surface areas of NP and NV. The total areas per patient were organized in a histogram, and logarithmically binned to test against power law and exponential distributions. Then, a computational model was constructed in Python 3.7 to suggest a mechanistic explanation for the observed distributions.
Results
Analysis of areas of NV across 189 images demonstrated a superior fit by the least squares method to a power law distribution (pā=ā0.014) with an R2 fit of 0.9672. Areas of NP over 794 images demonstrated a superior fit with an exponential distribution instead (pā=ā0.011). When the far periphery was excluded, the R2 fit for the exponential distribution was 0.9618. A computational model following the principles of self-organized criticality (SOC), akin to earthquake and forest fire models, matched these datasets.
Conclusions
These distributions inform what useful statistics may be applied to study of these imaging characteristics. Further, the difference in event distribution between NV and NP suggests that the two phenomena are mechanistically distinct. NV may follow SOC, propagating as a catastrophic event in an unpredictable manner.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request, pending ethical approval.
References
Flaxel CJ, Adelman RA, Bailey ST, Fawzi A, Lim JI, Vemulakonda GA, et al. Diabetic retinopathy preferred practice patternĀ®. Ophthalmology. 2020;127:P66āP145.
Ting DS, Cheung GC, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44:260ā77.
Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304:649ā56.
Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med. 1994;331:1480ā7.
Jenkins AJ, Joglekar MV, Hardikar AA, Keech AC, OāNeal DN, Januszewski AS. Biomarkers in diabetic retinopathy. Rev Diabet Stud. 2015;12:159.
Neubauer AS, Kernt M, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW. Nonmydriatic screening for diabetic retinopathy by ultra-widefield scanning laser ophthalmoscopy (Optomap). Graefes Arch Clin Exp Ophthalmol. 2008;246:229ā35.
Wilson PJ, Ellis JD, MacEwen CJ, Ellingford A, Talbot J, Leese GP. Screening for diabetic retinopathy: a comparative trial of photography and scanning laser ophthalmoscopy. Ophthalmologica. 2010;224:251ā7.
Yu G, Aaberg MT, Patel TP, Iyengar RS, Powell C, Tran A, et al. Quantification of retinal nonperfusion and neovascularization with ultrawidefield fluorescein angiography in patients with diabetes and associated characteristics of advanced disease. JAMA Ophthalmol. 2020;138:680ā8.
Nicholson L, Ramu J, Chan EW, Bainbridge JW, Hykin PG, Talks SJ, et al. Retinal nonperfusion characteristics on ultra-widefield angiography in eyes with severe nonproliferative diabetic retinopathy and proliferative diabetic retinopathy. JAMA Ophthalmol. 2019;137:626ā31.
Sun JK. Clinical applicability of assessing peripheral nonperfusion on ultra-widefield angiography: predicting proliferative diabetic retinopathy. JAMA Ophthalmol. 2019;137:632ā3.
Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991;98:786ā806.
Wong TY, Sun J, Kawasaki R, Ruamviboonsuk P, Gupta N, Lansingh VC, et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology. 2018;125:1608ā22.
Sadda SR, Nittala MG, Taweebanjongsin W, Verma A, Velaga SB, Alagorie AR, et al. Quantitative assessment of the severity of diabetic retinopathy. Am J Ophthalmol. 2020;218:342ā52.
Russell JF, Shi Y, Scott NL, Gregori G, Rosenfeld PJ. Longitudinal angiographic evidence that intraretinal microvascular abnormalities can evolve into neovascularization. Ophthalmol Retina. 2020;4:1146ā50.
Ehlers JP, Jiang AC, Boss JD, Hu M, Figueiredo N, Babiuch A, et al. Quantitative ultra-widefield angiography and diabetic retinopathy severity: an assessment of panretinal leakage index, ischemic index and microaneurysm count. Ophthalmology. 2019;126:1527ā32.
Silva PS, Cavallerano JD, Haddad NM, Kwak H, Dyer KH, Omar AF, et al. Peripheral lesions identified on ultrawide field imaging predict increased risk of diabetic retinopathy progression over 4 years. Ophthalmology. 2015;122:949ā56.
Shao D, He S, Ye Z, Zhu X, Sun W, Fu W, et al. Identification of potential molecular targets associated with proliferative diabetic retinopathy. BMC Ophthalmol. 2020;20:143.
Niranjan G, Srinivasan AR, Srikanth K, Pruthu G, Reeta R, Ramesh R, et al. Evaluation of circulating plasma VEGF-A, ET-1 and magnesium levels as the predictive markers for proliferative diabetic retinopathy. Indian J Clin Biochem. 2019;34:352ā6.
Croft DE, van Hemert J, Wykoff CC, Clifton D, Verhoek M, Fleming A, et al. Precise montaging and metric quantification of retinal surface area from ultra-widefield fundus photography and fluorescein angiography. Ophthalmic Surg Lasers Imaging Retina. 2014;45:312ā7.
Harris CR, Millman KJ, van der Walt SJ, Gommers R, Virtanen P, Cournapeau D, et al. Array programming with NumPy. Nature. 2020;585:357ā62.
Hunter JD. Matplotlib: A 2D graphics environment. Comput Sci Eng. 2007;9:90ā95.
Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye. 2004;18:963ā83.
StefĆ”nsson E, Chan YK, Bek T, Hardarson SH, Wong D, Wilson D. Laws of physics help explain capillary non-perfusion in diabetic retinopathy. Eye. 2018;32:210ā2.
Bak P. How nature works: the science of self-organized criticality. Springer Science & Business Media; 2013.
Aegerter C, GĆ¼nther R, Wijngaarden R. Avalanche dynamics, surface roughening, and self-organized criticality: experiments on a three-dimensional pile of rice. Phys Rev E. 2003;67:051306.
Clar S, Drossel B, Schwabl F. Forest fires and other examples of self-organized criticality. J Phys: Condens Matter. 1996;8:6803.
National Earthquake Prediction Evaluation Council (NEPEC) Working Group. Earthquake research at Parkfield, California, 1993 and beyond: Report of the National Earthquake Prediction Evaluation Council (NEPEC) Working Group to evaluate the Parkfield earthquake prediction experiment, Open File Report 93-622, Vol. 1116. Reston, VA: US Government Printing Office U.S. Geological Survey; 1994.
Ra H, Park JH, Baek JU, Baek J. Relationships among retinal nonperfusion, neovascularization, and vascular endothelial growth factor levels in quiescent proliferative diabetic retinopathy. J Clin Med. 2020;9:1462.
Spaide RF. Choriocapillaris flow features follow a power law distribution: implications for characterization and mechanisms of disease progression. Am J Ophthalmol. 2016;170:58ā67.
Acknowledgements
The authors would also like to thank Dave Musch, PhD and Marta Gilson, PhD who are both affiliated with the University of Michigan for their insightful discussion and preliminary univariate statistical analyses.
Funding
This work was supported by the National Eye Institute grant 1K08EY027458, 1R01EY033000, and 1R41EY031219 (YMP), the University of Michigan Department of Ophthalmology and Visual Sciences, unrestricted departmental support from Research to Prevent Blindness, generous support of the Helmut F. Stern Career Development Professorship in Ophthalmology and Visual Sciences (YMP), and the Heed Ophthalmic Foundation. These funding organizations were not involved with the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
GY, TPP and YMP obtained ethical approval. GY, LA and TPP collected data. GY, TPP, LA, NB and BKY performed data analysis. CP performed statistical analysis. BKY and NB wrote the main manuscript text. YMP provided supervision and revised the manuscript. All listed authors have approved the submitted version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisherās note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Young, B.K., Bommakanti, N., Yu, G. et al. Retinal neovascularization as self-organized criticality on ultra-widefield fluorescein angiography imaging of diabetic retinopathy. Eye 37, 2795ā2800 (2023). https://doi.org/10.1038/s41433-023-02422-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41433-023-02422-1